98 related articles for article (PubMed ID: 8384380)
1. Increased plasma thrombomodulin in cancer patients.
Lindahl AK; Boffa MC; Abildgaard U
Thromb Haemost; 1993 Feb; 69(2):112-4. PubMed ID: 8384380
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of an enzyme immunoassay for plasma thrombomodulin].
Amano K; Kaku M; Inaba H; Ueda M; Fukutake K; Arai M; Yorifuji H; Fujimaki M
Rinsho Byori; 1991 Sep; 39(9):967-71. PubMed ID: 1658417
[TBL] [Abstract][Full Text] [Related]
3. Fluctuations in plasma levels of thrombomodulin in patients with DIC.
Amano K; Tateyama M; Inaba H; Fukutake K; Fujimaki M
Thromb Haemost; 1992 Oct; 68(4):404-6. PubMed ID: 1333099
[TBL] [Abstract][Full Text] [Related]
4. [Evidence of elevated soluble plasma thrombomodulin in atherosclerosis].
Conri C; Seigneur M; Constans J; Mercier P; Baste JC; Dufourcq P; Boisseau MR
J Mal Vasc; 1993; 18(2):112-8. PubMed ID: 8394402
[TBL] [Abstract][Full Text] [Related]
5. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
Werther K; Christensen IJ; Brünner N; Nielsen HJ
Eur J Surg Oncol; 2000 Nov; 26(7):657-62. PubMed ID: 11078612
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tract.
Hejna M; Hamilton G; Brodowicz T; Haberl I; Fiebiger WC; Scheithauer W; Virgolini I; Köstler WJ; Oberhuber G; Raderer M
Anticancer Res; 2001; 21(2A):1183-7. PubMed ID: 11396161
[TBL] [Abstract][Full Text] [Related]
7. Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies.
Ishii H; Nakano M; Tsubouchi J; Ishikawa T; Uchiyama H; Hiraishi S; Tahara C; Miyajima Y; Kazama M
Thromb Haemost; 1990 Apr; 63(2):157-62. PubMed ID: 2163551
[TBL] [Abstract][Full Text] [Related]
8. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis.
Tripodi A; Primignani M; Chantarangkul V; Dell'Era A; Clerici M; de Franchis R; Colombo M; Mannucci PM
Gastroenterology; 2009 Dec; 137(6):2105-11. PubMed ID: 19706293
[TBL] [Abstract][Full Text] [Related]
9. [Plasma neuropeptide Y (NPY) levels in patients with gastric and colorectal carcinomas].
Li Y; Chen S; Li Z
Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):213-5. PubMed ID: 10921011
[TBL] [Abstract][Full Text] [Related]
10. [Soluble thrombomodulin: a specific parameter of endothelial injury].
Kazama M
Rinsho Ketsueki; 1991 Feb; 32(2):103-7. PubMed ID: 1851235
[TBL] [Abstract][Full Text] [Related]
11. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
[TBL] [Abstract][Full Text] [Related]
12. Endothelial protein C receptor plasma levels increase in chronic liver disease, while thrombomodulin plasma levels increase only in hepatocellular carcinoma.
Biguzzi E; Franchi F; Bucciarelli P; Colombo M; Romeo R
Thromb Res; 2007; 120(2):289-93. PubMed ID: 17049585
[TBL] [Abstract][Full Text] [Related]
13. High plasma levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer.
Lindahl AK; Sandset PM; Abildgaard U; Andersson TR; Harbitz TB
Acta Chir Scand; 1989 Aug; 155(8):389-93. PubMed ID: 2596246
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212
[TBL] [Abstract][Full Text] [Related]
15. Impaired binding of thrombin to thrombomodulin is associated with risk of deep vein thrombosis.
Suehisa E; Kawasaki T; Toku M; Hidaka Y
Thromb Res; 2008; 123(1):85-92. PubMed ID: 18590927
[TBL] [Abstract][Full Text] [Related]
16. Thrombomodulin-mediated catabolism of protein C by pleural mesothelial and vascular endothelial cells.
Iakhiaev AV; Rezaie AR; Idell S
Thromb Haemost; 2007 Sep; 98(3):627-34. PubMed ID: 17849052
[TBL] [Abstract][Full Text] [Related]
17. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer.
Nakayama Y; Sako T; Shibao K; Okazaki K; Rempo N; Onitsuka K; Minagawa N; Akahane K; Nagashima N; Nagata N; Itoh H
Anticancer Res; 2002; 22(4):2437-42. PubMed ID: 12174940
[TBL] [Abstract][Full Text] [Related]
19. Coagulopathy after successful cardiopulmonary resuscitation following cardiac arrest: implication of the protein C anticoagulant pathway.
Adrie C; Monchi M; Laurent I; Um S; Yan SB; Thuong M; Cariou A; Charpentier J; Dhainaut JF
J Am Coll Cardiol; 2005 Jul; 46(1):21-8. PubMed ID: 15992630
[TBL] [Abstract][Full Text] [Related]
20. Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer.
Barber MD; Fearon KC; Ross JA
Clin Sci (Lond); 1999 Jan; 96(1):83-7. PubMed ID: 9857110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
